1,125 assets in Non-Small Cell Lung Carcinoma

Therapeutic assets addressing Non-Small Cell Lung Carcinoma, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Doxycycline Non-Small Cell Lung Carcinoma	Janssen Research & Development, LLC	P2	CCC (48)
Dynamos Non-Small Cell Lung Carcinoma	Merck Sharp & Dohme LLC	P2	CCC (48)
dzd9008 Non-Small Cell Lung Carcinoma	Dizal Pharmaceuticals	P2	CCC (48)
Elironrasib Non-Small Cell Lung Carcinoma	Revolution Medicines, Inc.	P1/2	CCC (48)
Fluoromisonidazole Non-Small Cell Lung Carcinoma	National Cancer Institute (NCI)	P2	CCC (48)
Foritinib Succinate Non-Small Cell Lung Carcinoma	Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.	P3	CCC (48)
fyb206 Non-Small Cell Lung Carcinoma	Formycon AG	P3	CCC (48)
Grt-C903 Non-Small Cell Lung Carcinoma	National Cancer Institute (NCI)	P1/2	CCC (48)
Grt-R904 Non-Small Cell Lung Carcinoma	National Cancer Institute (NCI)	P1/2	CCC (48)
hd204 Non-Small Cell Lung Carcinoma	Prestige Biopharma Limited	P3	CCC (48)
HM06 Non-Small Cell Lung Carcinoma	Taiho Pharmaceutical Co., Ltd.	P1/2	CCC (48)
hs-10375 Non-Small Cell Lung Carcinoma	Jiangsu Hansoh Pharmaceutical Co., Ltd.	P1/2	CCC (48)
hs-10376 Non-Small Cell Lung Carcinoma	Jiangsu Hansoh Pharmaceutical Co., Ltd.	P1/2	CCC (48)
Huaier Granule Non-Small Cell Lung Carcinoma	Xin Ye	P3	CCC (48)
Human Immunoglobulins Non-Small Cell Lung Carcinoma	VA Office of Research and Development	P1/2	CCC (48)
Humanized Monoclonal Anti-Fgfr1 Antibody Om-Rca-01 Non-Small Cell Lung Carcinoma	Kidney Cancer Research Bureau	P1/2	CCC (48)
Immunoglobulin G1 [240-Alanine,241-Alanine], Anti-(Human Folate Receptor ?) (Human Monoclonal Pro1184 ?1-Chain, Complex With Human Monoclonal Pro1184 ?-Chain, Dimer, 214??,214???,226,226?,232,232?,235,235?-Octakis(Thioether) With N6-[39-[Bis(1-Deoxy-D-Glucitol-1-Yl)Amino]-1-Oxo-4,7,10,13,16,19,22,25,28,31,34,37-Dodecaoxanonatriacont-1-Yl]-N2-[6-(3-Mercapto-2,5-Dioxo-1-Pyrrolidinyl)-1-Oxohexyl]-L-Lysyl-L-Valyl-N5-(Aminocarbonyl)-N-[4-[[[[[(1S,9S)-9-Ethyl-5-Fluoro-2,3,9,10,13,15-Hexahydro-9-Hydroxy-4-Methyl-10,13-Dioxo-1H,12H-Benzo[De]Pyrano[3?,4?:6,7]Indolizino[1,2-B]Quinolin-1-Yl]Amino]Carbonyl]Oxy]Methyl]Phenyl]-L-Ornithinamide Non-Small Cell Lung Carcinoma	Genmab	P2	CCC (48)
Immunoglobulin G1 [300-Alanine], Anti-(Human Cd73 Antigen) (Human-Mus Musculus Monoclonal Tj004309 ?1-Chain), Disulfide With Human-Mus Musculus Monoclonal Tj004309 ?-Chain, Dimer Non-Small Cell Lung Carcinoma	I-Mab Biopharma US Limited	P2	CCC (48)
Intismeran Autogene Non-Small Cell Lung Carcinoma	Merck Sharp & Dohme LLC	P3	CCC (48)
Iov-4001 Non-Small Cell Lung Carcinoma	Iovance Biotherapeutics, Inc.	P1/2	CCC (48)
Iruplinalkib Non-Small Cell Lung Carcinoma	Peking University Shenzhen Hospital	P2	CCC (48)
Jin-A02 Non-Small Cell Lung Carcinoma	J Ints Bio	P1/2	CCC (48)
Letrozole Non-Small Cell Lung Carcinoma	BeOne Medicines	P2	CCC (48)
Lifileucel Non-Small Cell Lung Carcinoma	Shanghai Juncell Therapeutics	P2	CCC (48)
m701 pleural infusion Non-Small Cell Lung Carcinoma	Wuhan YZY Biopharma Co., Ltd.	P1/2	CCC (48)
Methotrexate Non-Small Cell Lung Carcinoma	Tianjin Medical University Cancer Institute and Hospital	P2	CCC (48)
Mirdametinib Non-Small Cell Lung Carcinoma	Centre Georges Francois Leclerc	P2	CCC (48)
Montelukast Non-Small Cell Lung Carcinoma	NYU Langone Health	P2	CCC (48)
Nanocrystalline Megestrol Acetate Suspension Non-Small Cell Lung Carcinoma	Hunan Province Tumor Hospital	P3	CCC (48)
Neladalkib Non-Small Cell Lung Carcinoma	Nuvalent Inc.	P3	CCC (48)
Pixatimod Non-Small Cell Lung Carcinoma	Diwakar Davar	P2	CCC (48)
Recombinant Human Adenovirus Type 5 Non-Small Cell Lung Carcinoma	Henan Cancer Hospital	P2	CCC (48)
Rmc-6236 Non-Small Cell Lung Carcinoma	Tango Therapeutics, Inc.	P1/2	CCC (48)
Shr-1826 Non-Small Cell Lung Carcinoma	Suzhou Suncadia Biopharmaceuticals Co., Ltd.	P2	CCC (48)
Si-B003 Non-Small Cell Lung Carcinoma	Sichuan Baili Pharmaceutical Co., Ltd.	P2	CCC (48)
SLC391 Non-Small Cell Lung Carcinoma	SignalChem Lifesciences Corporation	P1/2	CCC (48)
TAS0953 Non-Small Cell Lung Carcinoma	Taiho Pharmaceutical Co., Ltd.	P1/2	CCC (48)
tg01 Non-Small Cell Lung Carcinoma	Georgetown University	P2	CCC (48)
Tobemstomig Non-Small Cell Lung Carcinoma	Hoffmann-La Roche	P2	CCC (48)
Tq-B3525 Non-Small Cell Lung Carcinoma	Chia Tai Tianqing Pharmaceutical Group Co., Ltd.	P1/2	CCC (48)
Trabedersen Non-Small Cell Lung Carcinoma	University of Nebraska	P2	CCC (48)
Transcon Il-2 Β/Γ Non-Small Cell Lung Carcinoma	Ascendis Pharma Oncology Division A/S	P1/2	CCC (48)
Transcon Tlr7/8 Agonist Non-Small Cell Lung Carcinoma	Ascendis Pharma Oncology Division A/S	P1/2	CCC (48)
Tri-611 Non-Small Cell Lung Carcinoma	TRIANA Biomedicines, Inc.	P1/2	CCC (48)
ty-1091 Non-Small Cell Lung Carcinoma	TYK Medicines, Inc	P1/2	CCC (48)
Vedolizumab Non-Small Cell Lung Carcinoma	M.D. Anderson Cancer Center	P1/2	CCC (48)
wj13404 tablets Non-Small Cell Lung Carcinoma	Suzhou Junjing BioSciences Co., Ltd.	P1/2	CCC (48)
Zelenectide Pavedotin Non-Small Cell Lung Carcinoma	BicycleTx Limited	P2	CCC (48)
1.0% ip-001 for Non-Small Cell Lung Carcinoma	Immunophotonics, Inc.	P1/2	CC (47)
Adg 106 Non-Small Cell Lung Carcinoma	National University Hospital, Singapore	P1/2	CC (47)

Showing 401 to 450 of 1,125 assets

PreviousPage 9 of 23Next